BioCentury
ARTICLE | Clinical News

TLN-4601: Phase II start

April 14, 2008 7:00 AM UTC

This quarter, Thallion will begin a North American Phase II trial to evaluate IV TLN-4601 as monotherapy in 40 patients. ...